English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Pharma & Biotech Healthcare & Pharm
Avance Clinical and Medidata Celebrate Strategic Partnership and Inhouse Expert Accreditation Milestones
Feb 26, 2021 16:00 HKT
Maculus Therapeutix welcomes Privity, Prepares Capital Raise for Novel Drug Delivery Platform
Feb 19, 2021 07:00 HKT
ALG Health Receives NIOSH Surgical Rating on Three Of Its American Made N95 Respirators
Feb 15, 2021 17:00 HKT
Suntrap Discovered 'LeSoleil' for COVID-19 and the Epidemic
Feb 14, 2021 20:00 HKT
Cofttek, China's Largest Manufacturer of PEA, Draws Attention of Investors
Feb 14, 2021 01:00 HKT
Apollomics, Inc. Licenses a Targeted, Active Checkpoint Control Immunotherapy for Greater China and South Africa
Feb 12, 2021 13:00 HKT
Novamind Announces Strategic Investment in Bionomics to Support PTSD Clinical Trial
Feb 11, 2021 21:00 HKT
Apollomics, Inc. and Iterion Therapeutics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Tegavivint in Greater China
Feb 11, 2021 11:00 HKT
Apollomics, Inc. and Edison Oncology Announce Licensing Agreement for Novel Protein Tyrosine Kinase Inhibitor Targeting Solid Tumors
Feb 10, 2021 10:10 HKT
[A Share Highlight] Intco Medical (300677:CH) Announced Record High Net Profit with Planned H-share Listing To Propel Expansion
Feb 10, 2021 09:30 HKT
JBM (Healthcare) Limited Debuts on The Main Board of SEHK
Feb 05, 2021 16:28 HKT
China Medical System (0867.HK) Acquires a Dermatology Specialty Company: A Tough Player the Race
Feb 05, 2021 15:33 HKT
Olympus Supports Dissemination of Endoscopic Procedures for Colorectal Cancer in Russia
Feb 04, 2021 10:00 HKT
Two Immigrants, One Unique Plan For A Biopharma
Feb 03, 2021 06:00 HKT
Lasting Antiviral Effect against Covid-19 virus (SARS-CoV-2) by TAKEX CLEAN EXTRA
Feb 02, 2021 11:00 HKT
Olympus launches comprehensive global educational platform for healthcare professionals
Feb 01, 2021 08:00 HKT
Shanghai Longyao Chief Scientist Professor Xuanming Yang published a research article on optimizing CAR-T cells function with independently expressed full-length OX40
Jan 29, 2021 08:00 HKT
China Biotech Services LY007 Cell Injection Obtained Clinical Trial Approval Letter
Jan 28, 2021 09:50 HKT
Broncus Holding Corporation Closed Series D Financing
Jan 28, 2021 09:30 HKT
New benchmark set to deliver optimal osteoporosis care throughout Asia Pacific
Jan 28, 2021 07:00 HKT
Next >>
Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: